Catherine Sanders has more than 10 years of experience in the field of immunosequencing. She is currently Senior Director, Scientific Liaisons at Adaptive Biotechnologies responsible for establishing partnerships with pharmaceutical companies and collaborations with key opinion leaders in oncology, hematology, transplantation, infectious disease and autoimmunity. Dr. Sanders received a Ph.D. in immunopathology and a M.S. in pathology from the University of Mississippi Medical Center in Jackson where she focused on TLR, chemokine receptor, and cytokine expression in HIV-infected T lymphocyte subsets. She also holds a BS degree in Medical Technology from Mississippi State University and received her board certification (ASCP) from Vanderbilt University Medical Center.